Literature DB >> 31839376

[Information around organized breast cancer screening. Do INCa and Cancer Rose meet criteria for decision aids?]

X Gocko1, M Fondacci2, C Dibi2, C Plotton2.   

Abstract

BACKGROUND: Controversies around organized breast cancer screening emphasize the need for information for women. In France, the institute of cancer (INCa) is in charge of conveying this information. Cancer Rose's website (CR) provides complementary information considering INCa's incomplete. The objective of this study was to identify if these informations meet criteria for decision aid.
METHODS: Information documents were selected and analyzed using International Patient Decision Aid Standards (IPDAS). Each item was noted A (absent), P (present) or I (present but incomplete).
RESULTS: Information booklet and press kit for INCa and studies section for CR were the document meeting most criteria. The document meeting fewer criteria were the INCa's video and information leaflet for CR. Videos are more accessible tools for people with lower levels of health literacy. INCa's video did not present the risks of screening and CR's emphasized the risks.
CONCLUSION: These documents have not been evaluated for intelligibility, clarity and readability. Addressing these criteria limits social inequities and improves health literacy.
Copyright © 2019 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Breast cancer; Cancer du sein; Communication; Dépistage; Prise de décision partagée; Screening; Shared decision making

Year:  2019        PMID: 31839376     DOI: 10.1016/j.respe.2019.09.011

Source DB:  PubMed          Journal:  Rev Epidemiol Sante Publique        ISSN: 0398-7620            Impact factor:   1.019


  1 in total

1.  Study on the Effect of Positive Psychological Intervention Based on PERMA Model on Perioperative Patients with AIDS Complicated with Breast Cancer.

Authors:  Lingmei Luo; Ying Li; Zhou Zhou; Saifen Yang; Yao Qin; Hua Peng; Yirong Wang; Zhe Li; Tianqin Yin
Journal:  Comput Math Methods Med       Date:  2022-08-08       Impact factor: 2.809

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.